MoneyWorks4Me

Ami Organics informs about statement of deviation & variation

12 Aug 2022 Evaluate
Pursuant to Regulation 32(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulation, 2015 Ami Organics has informed that it enclosed the statement of deviation(s) or variation(s) in utilisation of IPO Proceeds, for quarter ended June 30, 2022 pertaining to the Initial Public Offer of equity shares of the Company in the prescribed format.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..